Jul 2018 $3 M No. 4 $2 to $10 million 5
EnteroMedics Inc: Raise no. 4, Jul 2018 × Investors in this round 5 investors had bought by the notice of Jul 13, 2018: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for EnteroMedics Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $12,414
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dan Gladney · Executive Officer, Director Scott Youngstrom · Executive Officer Gary Blackford · Director Jon Tremmel · Director Lori McDougal · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in FL, NJ, NY, TX Remarks in the notice On fees: “H.C. Wainwright received the above sales commission in connection with the private placement of warrants. The HCW Warrants were issued to H.C. Wainwright in connection with a registered direct offering by the Company, which is not reported on this Form D.”On the amounts: “"The warrants and underlying shares of common stock include warrants (i) to purchase 1,241,382 shares of common stock issued to certain institutional investors and (ii) to purchase 86,897 shares of common stock to H.C. Wainwright (""HCW Warrants"")."”Signed by Scott Youngstrom, Cfo. Source: SEC Form D, newest notice filed Jul 13, 2018. Read the notice at the SEC .
options SEC Jun 2018 $2 M No. 3 Under $2 million 5
EnteroMedics Inc: Raise no. 3, Jun 2018 × Investors in this round 5 investors had bought by the notice of Jun 25, 2018: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for EnteroMedics Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $4,108
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dan Gladney · Executive Officer, Director Scott Youngstrom · Executive Officer Gary Blackford · Director Jon Tremmel · Director Lori McDougal · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in FL, NJ, NY Remarks in the notice On fees: “H.C. Wainwright received the above sales commission in connection with the private placement of warrants. The HCW Warrants were issued to H.C. Wainwright in connection with a registered direct offering by the Company, which is not reported on this Form D.”On the amounts: “"The warrants and underlying shares of common stock include warrants (i) to purchase 469,490 shares of common stock issued to certain institutional investors and (ii) to purchase 22,802 shares of common stock to H.C. Wainwright (""HCW Warrants"")."”Signed by Scott Youngstrom, CFO and Chief Compliance Officer. Source: SEC Form D, newest notice filed Jun 25, 2018. Read the notice at the SEC .
options SEC Jun 2018 $1 M No. 2 Under $2 million 4
EnteroMedics Inc: Raise no. 2, Jun 2018 × Investors in this round 4 investors had bought by the notice of Jun 22, 2018: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for EnteroMedics Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $2,809
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dan Gladney · Executive Officer, Director Scott Youngstrom · Executive Officer Gary Blackford · Director Jon Tremmel · Director Lori McDougal · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in CA, FL, NJ, NY Remarks in the notice On fees: “H.C. Wainwright received the above sales commission in connection with the private placement of warrants. The HCW Warrants were issued to H.C. Wainwright in connection with a registered direct offering by the Company, which is not reported on this Form D.”On the amounts: “"The warrants and underlying shares of common stock include warrants (i) to purchase 280,929 shares of common stock issued to certain institutional investors and (ii) to purchase 26,220 shares of common stock to H.C. Wainwright (""HCW Warrants"")."”Signed by Scott Youngstrom, CFO and Chief Compliance Officer. Source: SEC Form D, newest notice filed Jun 22, 2018. Read the notice at the SEC .
options SEC Oct 2017 $61 M Issued in a merger or acquisition $50 to $250 million 13
EnteroMedics Inc: Private sale, Oct 2017 × Investors in this round 13 investors had bought by the notice of Oct 17, 2017: 13 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for EnteroMedics Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $61 M of $61 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dan W Gladney · Executive Officer, Director Naqeeb A Ansari · Executive Officer Peter M DeLange · Executive Officer Scott P Youngstrom · Executive Officer Bobby I Griffin · Director Gary D Blackford · Director Jon T Tremmel · Director Lori C McDougal · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Represents: value of common stock issued or convertible from series C convertible preferred stock; the liquidation preference of new preferred stock at $2.748774 per share of common stock; and $5 million cash.”Signed by Scott P. Youngstrom, CFO and Chief Compliance Officer. Source: SEC Form D, newest notice filed Oct 17, 2017. Read the notice at the SEC .
equity SEC May 2017 $31 M Issued in a merger or acquisition $10 to $50 million 41
EnteroMedics Inc: Private sale, May 2017 × Investors in this round 41 investors had bought by the notice of Jun 5, 2017: 41 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for EnteroMedics Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $31 M of $31 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Dan W Gladney · Executive Officer, Director Naqeeb A Ansari · Executive Officer Paul F Hickey · Executive Officer Peter M DeLange · Executive Officer Rajesh F Nihalani · Executive Officer Scott P Youngstrom · Executive Officer Bobby I Griffin · Director Carl D Goldfischer · Director Gary D Blackford · Director Jon T Tremmel · Director Lori C McDougal · Director Nicholas L Teti, Jr. · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “Represents the value of the Issuer's common shares issued in connection with the merger of BarioSurg, Inc., based on the last reported sale price of the Issuer's common shares on NASDAQ Stock Exchange on May 22, 2017 and $2 Million additional cash.”Signed by Scott P. Youngstrom, CFO and Chief Compliance Officer. Source: SEC Form D, newest notice filed Jun 5, 2017. Read the notice at the SEC .
equity SEC Feb 2009 $16 M No. 1 $10 to $50 million 33
EnteroMedics Inc: Raise no. 1, Feb 2009 × Investors in this round 33 investors had bought by the notice of Feb 27, 2009: 33 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for EnteroMedics Inc as a whole in other filings: see Investors below.
What the notice says
Amount sold $16 M of $17 M offered; $1 M still to sell
Smallest investment taken $5,000
What was sold equity, options or other rights to buy securities
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $617,444
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation People named in the notice Adrianus Jos Donders · Executive Officer Greg S Lea · Executive Officer Mark B Knudson · Executive Officer, Director Bobby Ivan Griffin · Director Carl Goldfischer · Director Catherine Friedman · Director Donald C Harrison · Director Ellen Koskinas · Director Jon T Tremmel · Director Luke Evnin · Director Nicholas L Teti · Director Paul Klingenstein · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Canaccord Adams Inc. (CRD 1020) · Boston, Ma Sold in no state named Remarks in the notice On the amounts: “Offering Closed”Signed by Greg S Lea, Cfo. Source: SEC Form D, newest notice filed Feb 27, 2009. Read the notice at the SEC .
equity, options SEC